Toddler with Duchenne Muscular Dystrophy Miraculously Walks

Toddler with Duchenne Muscular Dystrophy Miraculously Walks
0
(0)
While the CDC does not have enough data on current numbers of patients with Duchenne/Becker muscular dystrophy (DBMD), it is estimated that one out of every 5,600-7,700 males aged 5-24 years old in the US are affected by this rare muscle-wasting disease. Noticeable symptoms occur at around 2.5 years old, but in little Jenson Whitehouse’s case, he was diagnosed when he was just one year old, with his parents thinking he would never be able to walk.
Last December, after Garry and Chantal Whitehouse noticed their son having difficulty sitting up and crawling, they received sad news that their one-year-old, Jenson, had Duchenne Muscular Dystrophy. This meant that their child would have to grow up dependent on a wheelchair.
The most unexpected thing happened while the family was watching an episode of Big Build on television. Coincidentally, during a feature on a young boy with various health conditions, Jenson pulled himself up onto his walker and began walking around the room.
While the Whitehouse family are still aware of the severity of this disease, they are hopeful this miracle will last long enough for their son to experience more of his precious childhood. They are also hoping that others find out, and learn to remain hopeful in the face of the disease, despite the odds.

Because this rare disease commonly affects young boys and robs them of a chance to have a normal childhood and play sports, the American Football Coaches Association (AFCA), a 10,000-strong organization, and Parent Project Muscular Dystrophy (PPMD), the most prominent non-profit organization in the country dedicated to supporting DMD, came up with the Coach to Cure MD program.

[adrotate group=”3″]

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
×
Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
Latest Posts
  • Hockey player Ryan Getzlaf
  • Sarepta partnership
  • MYO-101 for LGMD2E
  • ICER review

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?